Evaluation of the tumor microenvironment in African American and non-Hispanic White patients with non-small cell lung cancer associated with PD-L1 expression or the presence of tertiary lymphoid structures.
Matthew R. Trendowski(Wayne State University), Heather M. Gibson(Wayne State University), Christine Neslund‐Dudas(Henry Ford Health System), Hirva Mamdani(Wayne State University), Valerie Ratliff(Wayne State University), Chrissy Lusk(Wayne State University), Julie L. Boerner(Wayne State University), Donovan Watza(Wayne State University), Ann G. Schwartz(The Barbara Ann Karmanos Cancer Institute), Angela S. Wenzlaff(The Barbara Ann Karmanos Cancer Institute), Fulvio Lonardo(Wayne State University)
Cited by 0
Related Papers
Immunotherapy in Lung Cancer: Current Landscape and Future Directions
|Frontiers in Immunology|2022|373
Trends in short-term survival from distant-stage cutaneous melanoma in the United States, 2001-2013 (CONCORD-3)
|JNCI Cancer Spectrum|2020|163
Familial Aggregation of Common Sequence Variants on 15q24-25.1 in Lung Cancer
|JNCI Journal of the National Cancer Institute|2008|152
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline
|Journal of Clinical Oncology|2022|125
Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline
|Journal of Clinical Oncology|2022|116